Kindred Healthcare, Inc. (KND) Misses Q3 EPS by 5c; Narrows FY12 Guidance Range
Tweet
Share
E-mailGet Alerts KND Hot Sheet
Price: $9.00 --0%
Financial Fact:
Gain (loss) on divestiture of operations: 0
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Gain (loss) on divestiture of operations: 0
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Kindred Healthcare, Inc. (NYSE: KND) reported Q3 EPS of $0.21, $0.05 worse than the analyst estimate of $0.26. Revenue for the quarter came in at $1.5 billion versus the consensus estimate of $1.53 million.
Kindred Healthcare, Inc. sees FY2012 EPS of $1.40-1.50, versus prior guidance of $1.35-1.55 and the consensus of $1.48.
Kindred Healthcare, Inc. sees FY2013 EPS of $1.20-1.40, versus the consensus of $1.28.
For earnings history and earnings-related data on Kindred Healthcare, Inc. (KND) click here.
Kindred Healthcare, Inc. sees FY2012 EPS of $1.40-1.50, versus prior guidance of $1.35-1.55 and the consensus of $1.48.
Kindred Healthcare, Inc. sees FY2013 EPS of $1.20-1.40, versus the consensus of $1.28.
For earnings history and earnings-related data on Kindred Healthcare, Inc. (KND) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- UBS says bull market has further to run
- Deutsche Bank monitors UK auto sales as Chinese exports grow
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
